Skip to content Skip to footer
Join our LinkedIn Group and be part of the conversation on AI in life sciences
Login
Login
Close
AI Life Sciences

2026 Prediction #1: No More Sandboxes: AI Enters the Core of Life Sciences

BlogMarch 3, 2026237Views0Likes0Comments
For the last several years, artificial intelligence in life sciences has largely lived in innovation labs and pilot programs—valuable but often disconnected from the workflows that actually drive regulatory approvals, market access, and clinical decision-making. In 2026, that changes. Our first prediction from MadeAi & CapeStart’s 2026 outlook, developed with insights from Angeline Dhas, Head…

Read More

Literature Reviews

Complete Guide to GenAI-enabled Literature Review for Life Sciences: MadeAi vs. Competitors

BlogFebruary 12, 2026176Views0Likes0Comments
Every professional in the life sciences knows the feeling: literature review is challenging, time-consuming, and above all, exhausting. This essential step in research can feel like a massive hurdle, slowing down innovation and consuming countless hours. Recognizing this frustration, MadeAi developed MadeAi-LR, a powerful GenAI-enabled solution designed to transform the literature review process. It provides the…

Read More

Literature Review

Literature Reviews: How AI is Revolutionizing Systematic Research

BlogFebruary 4, 2026110Views0Likes0Comments
In an era where scientific publications double every nine years and over 2.5 million new research papers are published each year, keeping your literature review up to date is nearly impossible. Enter the Living Literature Review, a significant shift that turns static research snapshots into continually evolving knowledge ecosystems. Why Traditional Literature Reviews Are Becoming…

Read More

Rare Disease

From Patient Voices to Actionable Insights: Why Social Media Listening Matters for Rare Disease Companies

BlogJanuary 30, 2026131Views0Likes0Comments
Understanding patient burden and unmet needs has always been essential in healthcare. But for rare diseases research, it is absolutely critical. When patient populations are small, heterogeneous, and often underserved, every insight carries weight. Yet traditional data sources—clinical trials, claims data, registries, and surveys—often fall short of capturing the lived reality of patients and caregivers…

Read More

FDA Literature Review

FDA Literature Review Requirements: Leveraging AI into Your Literature Review Strategy

BlogJanuary 23, 202686Views0Likes0Comments
Understanding FDA Literature Review Requirements The FDA requires literature reviews to ensure that regulatory decisions are based on solid scientific evidence. This isn't just about compiling papers; it's about systematically searching, appraising, and synthesizing published data to demonstrate safety, efficacy, and compliance. These requirements span multiple domains, from drug approvals to medical devices and health…

Read More